Cognitive effects of cilostazol in Alzheimer's dementia patients with peripheral arterial occlusive disease: A case-control study

CONCLUSIONS: In AD patients with peripheral arterial occlusive disease who have received Food and Drug Administration-approved pharmacotherapy, cilostazol, as an antiplatelet, may help to preserve general cognitive function, with significant preservation in category fluency. Geriatr Gerontol Int 2023; ••: ••-••.PMID:36682741 | DOI:10.1111/ggi.14542

Source: Atherosclerosis - January 22, 2023 Category: Cardiology Authors: Ching-Fang Chien Ling-Chun Huang Kuan-Ying Li Yuan-Han Yang Source Type: research